FDA

The Nature’s Own Pet Chews Bully Bites were recalled due to possible Salmonella contamination.

Zoetis' Dectomax-CA1 is the first drug to receive conditional approval in the US for addressing this type of parasitic infestation.

The revision removes language about fatal vaccine-induced disease from the skin allergy drug's label.

The agency found that Gallant’s data provides reasonable expectation of effectiveness.

The parasiticide also treats Dermanyssus gallinae, also known as red mites.

The food was tested prior to a cat testing positive for H5N1 highly pathogenic avian influenza prior to ingesting one of the infected lot numbers.

Gamrozyne is the first generic version of Zactran, a pioneer product.

Two lots of its dog and cat food are being recalled due to Salmonella and Listeria monocytogenes contamination.

The company voluntarily recalled its 2 lots of product due to potential health risks.

Three different bacteria were found in different dog food products. One is associated with kidney failure and neurologic issues in humans.

This latest approval builds on an earlier liquid formulation of generic methimazole for feline hyperthyroidism, which received FDA clearance earlier this month

The funding will support Gallant’s treatment for refractory feline chronic gingivostomatitis, which is in development.

The Magnetom Flow.Ace also uses AI technology for faster scans and image reconstruction.

This approval means that CPMA can be used to prevent canine parvovirus in puppies exposed to the virus.

The FDA was particularly concerned about the selling of unapproved CBD products for food-producing animals.

The latest canine otitis externa medication is the only FDA-approved, 1-dose, in-clinic treatment for Pseudomonas aeruginosa and other pathogens.

Dechra’s Otiserene is a single-dose, long-acting product that utilizes marbofloxacin

This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of animal testing

The FDA has approved the new indication for Zoetis' Simparica Trio

Savage Pet recalled large and small boxes of its cat food chicken due to potential avian influenza risks

Felycin-CA1 manages ventricular hypertrophy in feline patients with subclinical hypertrophic cardiomyopathy

DuOtic received FDA approval March 2024 to treat canine patients

The novel therapy is the first drug for treating cats with hypertrophic cardiomyopathy

Dogs have experienced burn injuries following unsafe use of Megadyne grounding pads

The defendant co-conspirators defrauded potential pet owners through a animal rescue operation.

Indications are broadened for Zoetis products to include new protections against Asian longhorned ticks and tapeworms

Neurologic signs were reported with bedinvetmab injection use in dogs

The unapproved drugs claim to treat and control seizures in canine and feline patients